Filing Details
- Accession Number:
- 0001179110-17-001472
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-02 15:54:24
- Reporting Period:
- 2017-01-31
- Filing Date:
- 2017-02-02
- Accepted Time:
- 2017-02-02 15:54:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1345695 | Bruce Leicher | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-01-31 | 5,000 | $18.00 | 178,222 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2015.
- This balance of shares beneficially owned reflects 646 shares acquired under the employee stock plan at a purchase price of $9.64 per share on January 31, 2017.
Billionaire Hedge Funds
